Emi Ibuki

556 total citations
32 papers, 346 citations indexed

About

Emi Ibuki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Emi Ibuki has authored 32 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 7 papers in Surgery. Recurrent topics in Emi Ibuki's work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Emi Ibuki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Emi Ibuki collaborates with scholars based in Japan and United States. Emi Ibuki's co-authors include Reiji Haba, Kyuichi Kadota, Hiroyasu Yokomise, Ryou Ishikawa, Yoshio Kushida, Tetsuhiko Go, Norimitsu Kadowaki, Kosuke Inoue, Tomoya Ishii and Naomi Katsuki and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and The American Journal of Surgical Pathology.

In The Last Decade

Emi Ibuki

25 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emi Ibuki Japan 9 260 94 72 71 37 32 346
Keizo Misumi Japan 15 345 1.3× 83 0.9× 115 1.6× 100 1.4× 53 1.4× 33 480
F. Maldonado Mexico 8 230 0.9× 130 1.4× 69 1.0× 157 2.2× 56 1.5× 14 391
Stefano Donghi Italy 9 288 1.1× 137 1.5× 99 1.4× 47 0.7× 22 0.6× 26 374
Piotr Rudziński Poland 11 248 1.0× 99 1.1× 51 0.7× 57 0.8× 68 1.8× 35 362
Giulia Veronesi Italy 10 260 1.0× 172 1.8× 103 1.4× 51 0.7× 34 0.9× 23 382
Xiangyang Yu China 15 223 0.9× 179 1.9× 96 1.3× 64 0.9× 95 2.6× 43 445
Shenhai Wei China 12 240 0.9× 133 1.4× 92 1.3× 76 1.1× 106 2.9× 21 431
Chaoyang Liang China 8 221 0.8× 101 1.1× 80 1.1× 48 0.7× 95 2.6× 22 355
Sachiko Nasu Japan 11 201 0.8× 150 1.6× 57 0.8× 65 0.9× 86 2.3× 18 383
José Manuel Rodríguez-Paniagua Spain 6 357 1.4× 170 1.8× 46 0.6× 72 1.0× 41 1.1× 13 412

Countries citing papers authored by Emi Ibuki

Since Specialization
Citations

This map shows the geographic impact of Emi Ibuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Ibuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Ibuki more than expected).

Fields of papers citing papers by Emi Ibuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Ibuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Ibuki. The network helps show where Emi Ibuki may publish in the future.

Co-authorship network of co-authors of Emi Ibuki

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Ibuki. A scholar is included among the top collaborators of Emi Ibuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Ibuki. Emi Ibuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibuki, Emi, et al.. (2024). Case report: Para-testicular spindle cell lipoma suspected of well-differentiated liposarcoma. SHILAP Revista de lepidopterología. 4. 1400674–1400674.
2.
Tsuji, Takahiro, Harumi Saeki, Emi Ibuki, et al.. (2024). A case of fulminant cryofibrinogenemia with rapid renal dysfunction and toe necrosis. Renal Replacement Therapy. 10(1).
3.
Yoshida, Chihiro, et al.. (2023). RNF128 expression in lung adenocarcinoma is a favorable prognostic factor associated with decreased tumor‐associated macrophages. Thoracic Cancer. 14(17). 1581–1588. 2 indexed citations
4.
Yoshida, Chihiro, et al.. (2023). CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas. Clinical and Experimental Medicine. 23(8). 5191–5200.
5.
Ibuki, Emi, Kyuichi Kadota, Ryou Ishikawa, et al.. (2023). Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy. Heliyon. 10(1). e23928–e23928. 2 indexed citations
6.
Oshima, Minoru, Keiichi Okano, Hideki Kamada, et al.. (2022). P53 immunolabeling in EUS‐FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy. Journal of Hepato-Biliary-Pancreatic Sciences. 30(6). 802–814. 6 indexed citations
7.
Ushio, Yusuke, Tomohiro Kameda, S. Nakashima, et al.. (2022). Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report. Allergy Asthma and Clinical Immunology. 18(1). 84–84.
8.
Goto, Shunsuke, Hideyo Oguchi, Ken Sakai, et al.. (2022). Association between expanded criteria for living kidney donors and renal biopsy findings. Journal of Nephrology. 35(7). 1809–1818. 1 indexed citations
9.
10.
Ishikawa, Ryou, Kyuichi Kadota, Chihiro Yoshida, et al.. (2022). Prognostic impact of tumor-infiltrating lymphocytes and neutrophils in resected non-small cell lung carcinoma. Human Pathology. 125. 87–96. 5 indexed citations
11.
Yoshida, Chihiro, Hiroyasu Yokomise, Emi Ibuki, et al.. (2022). High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma. General Thoracic and Cardiovascular Surgery. 70(5). 455–462. 13 indexed citations
12.
Kadota, Kyuichi, Chihiro Yoshida, Emi Ibuki, et al.. (2022). MMP-7 expression is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas. Lung Cancer. 175. 125–130. 7 indexed citations
13.
Tohi, Yoichiro, Rikiya Taoka, Xia Zhang, et al.. (2022). Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer. International Journal of Molecular Sciences. 23(12). 6771–6771. 8 indexed citations
14.
Yoshida, Chihiro, Kyuichi Kadota, Emi Ibuki, et al.. (2021). Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas. Lung Cancer. 158. 91–96. 21 indexed citations
15.
Norikane, Takashi, Yuka Yamamoto, Makiko Murota, et al.. (2021). Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer. Nuclear Medicine Communications. 43(3). 304–309. 6 indexed citations
16.
Ibuki, Emi, Tadashi Sofue, Yoshio Kushida, et al.. (2020). Characteristic electron-microscopic features of cryofibrinogen-associated glomerulonephritis: a case report. BMC Nephrology. 21(1). 27–27. 9 indexed citations
17.
Go, Tetsuhiko, et al.. (2020). Two cases of nodular smooth muscle proliferation suspected of primary lung cancer from preoperative images: a case report. Journal of Cardiothoracic Surgery. 15(1). 179–179.
18.
Uchita, Kunihisa, Kenji Kanenishi, Hideki Kobara, et al.. (2018). Characteristic findings of high-grade cervical intraepithelial neoplasia or more on magnifying endoscopy with narrow band imaging. International Journal of Clinical Oncology. 23(4). 707–714. 10 indexed citations
19.
Kadota, Kyuichi, Yoshio Kushida, Ryou Ishikawa, et al.. (2018). Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma. Journal of Thoracic Oncology. 14(2). 245–254. 54 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keizo Misumi Breakdown of academic impact, for papers by F. Maldonado Breakdown of academic impact, for papers by Stefano Donghi Breakdown of academic impact, for papers by Piotr Rudziński Breakdown of academic impact, for papers by Giulia Veronesi Breakdown of academic impact, for papers by Xiangyang Yu Breakdown of academic impact, for papers by Shenhai Wei Breakdown of academic impact, for papers by Chaoyang Liang Breakdown of academic impact, for papers by Sachiko Nasu Breakdown of academic impact, for papers by José Manuel Rodríguez-Paniagua
Rankless by CCL
2026